Havermann, Susannah <br/><br/>
Modulation of the Nrf2 signalling pathway in Hct116 colon carcinoma cells by baicalein and its methylated derivative negletein.  [electronic resource] 

 -  Pharmaceutical biology  Sep 2016 
 - 1491-502 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>1744-5116 
<br/><br/><label>Standard No.: </label>10.3109/13880209.2015.1104703  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents, Phytogenic--therapeutic use<br/>Carcinoma--drug therapy<br/>Colonic Neoplasms--drug therapy<br/>Dose-Response Relationship, Drug<br/>Flavanones--pharmacology<br/>Flavones--pharmacology<br/>Gene Expression Regulation, Neoplastic<br/>HCT116 Cells<br/>Humans<br/>NF-E2-Related Factor 2--genetics<br/>Oxidation-Reduction<br/>Phosphorylation<br/>Proteasome Endopeptidase Complex--metabolism<br/>Protein Stability<br/>Proteolysis<br/>Signal Transduction--drug effects<br/>Time Factors<br/>Transcription, Genetic